• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

差异性 DNase I 超敏性揭示了依赖因子的染色质动力学。

Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics.

机构信息

Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts 02115, USA;

出版信息

Genome Res. 2012 Jun;22(6):1015-25. doi: 10.1101/gr.133280.111. Epub 2012 Apr 16.

DOI:10.1101/gr.133280.111
PMID:22508765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3371710/
Abstract

Transcription factor cistromes are highly cell-type specific. Chromatin accessibility, histone modifications, and nucleosome occupancy have all been found to play a role in defining these binding locations. Here, we show that hormone-induced DNase I hypersensitivity changes (ΔDHS) are highly predictive of androgen receptor (AR) and estrogen receptor 1 (ESR1) binding in prostate cancer and breast cancer cells, respectively. While chromatin structure prior to receptor binding and nucleosome occupancy after binding are strikingly different for ESR1 and AR, ΔDHS is highly predictive for both. AR binding is associated with changes in both local nucleosome occupancy and DNase I hypersensitivity. In contrast, while global ESR1 binding is unrelated to changes in nucleosome occupancy, DNase I hypersensitivity dynamics are also predictive of the ESR1 cistrome. These findings suggest that AR and ESR1 have distinct modes of interaction with chromatin and that DNase I hypersensitivity dynamics provides a general approach for predicting cell-type specific cistromes.

摘要

转录因子顺式作用元件高度具有细胞类型特异性。染色质可及性、组蛋白修饰和核小体占有率都被发现对这些结合位置的定义起着作用。在这里,我们展示了激素诱导的 DNA 酶 I 超敏性变化(ΔDHS)在前列腺癌和乳腺癌细胞中分别高度预测了雄激素受体(AR)和雌激素受体 1(ESR1)的结合。虽然在受体结合之前的染色质结构和结合之后的核小体占有率在 ESR1 和 AR 之间存在显著差异,但 ΔDHS 对两者都具有高度预测性。AR 结合与局部核小体占有率和 DNA 酶 I 超敏性变化都有关。相比之下,虽然全局 ESR1 结合与核小体占有率变化无关,但 DNA 酶 I 超敏性动态也可预测 ESR1 顺式作用元件。这些发现表明,AR 和 ESR1 与染色质的相互作用具有不同的模式,而 DNA 酶 I 超敏性动态为预测细胞类型特异性顺式作用元件提供了一种通用方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3420/3371710/20ab1ac4611d/1015fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3420/3371710/4cc2aa7c0291/1015fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3420/3371710/2930c8c14e79/1015fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3420/3371710/4c28c81e4420/1015fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3420/3371710/0a408c9ce975/1015fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3420/3371710/20ab1ac4611d/1015fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3420/3371710/4cc2aa7c0291/1015fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3420/3371710/2930c8c14e79/1015fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3420/3371710/4c28c81e4420/1015fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3420/3371710/0a408c9ce975/1015fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3420/3371710/20ab1ac4611d/1015fig5.jpg

相似文献

1
Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics.差异性 DNase I 超敏性揭示了依赖因子的染色质动力学。
Genome Res. 2012 Jun;22(6):1015-25. doi: 10.1101/gr.133280.111. Epub 2012 Apr 16.
2
GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility.GATA3 通过塑造增强子可及性在上游调控 FOXA1 介导的 ESR1 结合。
Genome Res. 2013 Jan;23(1):12-22. doi: 10.1101/gr.139469.112. Epub 2012 Nov 21.
3
Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancer.先驱因子GATA2在促进前列腺癌雄激素依赖性基因表达中的三重作用。
Nucleic Acids Res. 2014 Apr;42(6):3607-22. doi: 10.1093/nar/gkt1382. Epub 2014 Jan 13.
4
Cooperativity and equilibrium with FOXA1 define the androgen receptor transcriptional program.与FOXA1的协同作用和平衡决定了雄激素受体转录程序。
Nat Commun. 2014 May 30;5:3972. doi: 10.1038/ncomms4972.
5
SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin.小泛素样修饰蛋白连接酶PIAS1在前列腺癌细胞染色质上作为靶基因选择性雄激素受体共调节因子发挥作用。
Nucleic Acids Res. 2015 Jan;43(2):848-61. doi: 10.1093/nar/gku1375. Epub 2014 Dec 30.
6
Androgen receptor and estrogen receptor variants in prostate and breast cancers.前列腺癌和乳腺癌中的雄激素受体与雌激素受体变体
J Steroid Biochem Mol Biol. 2024 Jul;241:106522. doi: 10.1016/j.jsbmb.2024.106522. Epub 2024 Apr 17.
7
Chromatin accessibility reveals insights into androgen receptor activation and transcriptional specificity.染色质可及性揭示了雄激素受体激活和转录特异性的相关见解。
Genome Biol. 2012 Oct 3;13(10):R88. doi: 10.1186/gb-2012-13-10-r88.
8
Integrating multiple oestrogen receptor alpha ChIP studies: overlap with disease susceptibility regions, DNase I hypersensitivity peaks and gene expression.整合多个雌激素受体α ChIP 研究:与疾病易感性区域、DNase I 超敏峰和基因表达的重叠。
BMC Med Genomics. 2013 Oct 30;6:45. doi: 10.1186/1755-8794-6-45.
9
Crosstalk between androgen and pro-inflammatory signaling remodels androgen receptor and NF-κB cistrome to reprogram the prostate cancer cell transcriptome.雄激素与促炎信号之间的串扰重塑雄激素受体和核因子-κB顺反组,从而对前列腺癌细胞转录组进行重编程。
Nucleic Acids Res. 2017 Jan 25;45(2):619-630. doi: 10.1093/nar/gkw855. Epub 2016 Sep 26.
10
AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.雄激素受体对 AIB1 的隔离抑制了乳腺癌细胞中雌激素依赖性细胞周期蛋白 D1 的表达。
BMC Cancer. 2019 Nov 4;19(1):1038. doi: 10.1186/s12885-019-6262-4.

引用本文的文献

1
Estrogen Receptor Enhancers Sensitive to Low Doses of Hormone Specify Distinct Molecular and Biological Outcomes.对低剂量激素敏感的雌激素受体增强子决定了不同的分子和生物学结果。
bioRxiv. 2025 Aug 12:2025.08.08.669412. doi: 10.1101/2025.08.08.669412.
2
Altered cofactor recruitment and nucleosome dynamics underlie bisphenol A's impact on ERα-mediated transcriptional bursting.辅因子募集和核小体动力学的改变是双酚A对雌激素受体α介导的转录爆发产生影响的基础。
iScience. 2025 Jun 10;28(7):112864. doi: 10.1016/j.isci.2025.112864. eCollection 2025 Jul 18.
3
IGN: Invariable gene set-based normalization for chromatin accessibility profile data analysis.

本文引用的文献

1
Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time.雌激素通过跨时间的全基因表达鉴定的应激反应诱导雌激素剥夺耐药性乳腺癌细胞凋亡。
Proc Natl Acad Sci U S A. 2011 Nov 22;108(47):18879-86. doi: 10.1073/pnas.1115188108. Epub 2011 Oct 19.
2
Regulation of nucleosome landscape and transcription factor targeting at tissue-specific enhancers by BRG1.BRG1 调控组织特异性增强子的核小体景观和转录因子靶向。
Genome Res. 2011 Oct;21(10):1650-8. doi: 10.1101/gr.121145.111. Epub 2011 Jul 27.
3
Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity.
IGN:基于不变基因集的染色质可及性图谱数据分析归一化方法
Comput Struct Biotechnol J. 2025 Jan 23;27:501-507. doi: 10.1016/j.csbj.2025.01.018. eCollection 2025.
4
Non-coding genetic variants underlying higher prostate cancer risk in men of African ancestry.非洲裔男性中前列腺癌风险较高背后的非编码基因变异。
Res Sq. 2024 Dec 5:rs.3.rs-5485172. doi: 10.21203/rs.3.rs-5485172/v1.
5
Relaxin Modulates the Genomic Actions and Biological Effects of Estrogen in the Myometrium.松弛素调节子宫肌层中雌激素的基因组作用和生物学效应。
Endocrinology. 2024 Sep 26;165(11). doi: 10.1210/endocr/bqae123.
6
Relaxin Modulates the Genomic Actions and Biological Effects of Estrogen in the Myometrium.松弛素调节子宫肌层中雌激素的基因组作用和生物学效应。
bioRxiv. 2024 Aug 29:2024.04.15.589654. doi: 10.1101/2024.04.15.589654.
7
AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer.AIB1/SRC-3/NCOA3 在雌激素受体阳性乳腺癌中发挥作用。
Front Endocrinol (Lausanne). 2023 Aug 30;14:1250218. doi: 10.3389/fendo.2023.1250218. eCollection 2023.
8
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily-Update 2023.国际基础与临床药理学联盟第十三分会:核受体超家族-2023 更新。
Pharmacol Rev. 2023 Nov;75(6):1233-1318. doi: 10.1124/pharmrev.121.000436. Epub 2023 Aug 16.
9
Genome-wide chromatin accessibility landscape and dynamics of transcription factor networks during ovule and fiber development in cotton.棉纤维和胚珠发育过程中转录因子网络的全基因组染色质可及性景观和动态。
BMC Biol. 2023 Jul 31;21(1):165. doi: 10.1186/s12915-023-01665-4.
10
Cellular specificity of androgen receptor, coregulators, and pioneer factors in prostate cancer.雄激素受体、共调节因子和先驱因子在前列腺癌中的细胞特异性
Endocr Oncol. 2022 Sep 8;2(1):R112-R131. doi: 10.1530/EO-22-0065. eCollection 2022 Jan.
由 DNaseI 和 FAIRE 定义的开放染色质可识别出塑造细胞类型特征的调控元件。
Genome Res. 2011 Oct;21(10):1757-67. doi: 10.1101/gr.121541.111. Epub 2011 Jul 12.
4
A packing mechanism for nucleosome organization reconstituted across a eukaryotic genome.真核生物基因组上组装核小体的包装机制。
Science. 2011 May 20;332(6032):977-80. doi: 10.1126/science.1200508.
5
Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA.通过功能定义的不同类别增强子重编程转录,这些增强子由 eRNA 定义。
Nature. 2011 May 15;474(7351):390-4. doi: 10.1038/nature10006.
6
BINOCh: binding inference from nucleosome occupancy changes.BINOCh:从核小体占有率变化推断结合。
Bioinformatics. 2011 Jul 1;27(13):1867-8. doi: 10.1093/bioinformatics/btr279. Epub 2011 May 5.
7
A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells.雌激素信号在乳腺癌细胞中引发快速、广泛且短暂的转录反应。
Cell. 2011 May 13;145(4):622-34. doi: 10.1016/j.cell.2011.03.042. Epub 2011 May 5.
8
Extensive chromatin remodelling and establishment of transcription factor 'hotspots' during early adipogenesis.在早期脂肪生成过程中,广泛的染色质重塑和转录因子“热点”的建立。
EMBO J. 2011 Apr 20;30(8):1459-72. doi: 10.1038/emboj.2011.65. Epub 2011 Mar 22.
9
Chromatin accessibility pre-determines glucocorticoid receptor binding patterns.染色质可及性预先决定了糖皮质激素受体结合模式。
Nat Genet. 2011 Mar;43(3):264-8. doi: 10.1038/ng.759. Epub 2011 Jan 23.
10
Integrative model of genomic factors for determining binding site selection by estrogen receptor-α.雌激素受体-α结合位点选择的基因组因素综合模型。
Mol Syst Biol. 2010 Dec 21;6:456. doi: 10.1038/msb.2010.109.